default author photo

Jennifer A. Juno

University of Melbourne - Department of Microbiology and Immunology (DMI)

Melbourne, 3000

Australia

SCHOLARLY PAPERS

4

DOWNLOADS

274

TOTAL CITATIONS

5

Scholarly Papers (4)

1.

Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 th Dose Booster

Number of pages: 43 Posted: 29 Jun 2023
University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne, University of Melbourne - Departments of Medicine and Infectious Diseases at the Doherty Institute, University of Melbourne - Department of Microbiology and Immunology, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne, University of Melbourne, Flinders University, University of Melbourne, University of Melbourne, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Centre for Epidemiology and Biostatistics, University of Melbourne, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, SingHealth Duke-NUS Global Health Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), Flinders University, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Monash University - Monash Institute of Pharmaceutical Sciences, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Centre for Epidemiology and Biostatistics, Monash University - Monash Institute of Pharmaceutical Sciences and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 127 (569,079)

Abstract:

Loading...

SARS-CoV-2, vaccine, receptor binding domain, recombinant protein, mRNA, beta variant, phase I trial.

2.

Re: Integrated Immune Dynamics Define Correlates of COVID-19 Severity and Antibody Responses

Number of pages: 56 Posted: 13 Oct 2020
University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), The University of Sydney - Sydney Cytometry Core Research Facility, The University of Sydney - Charles Perkins Centre, The University of Sydney - Charles Perkins Centre, The University of Sydney - School of Computer Science, The University of Sydney - School of Computer Science, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, University of Melbourne - Peter Doherty Institute for Infection and Immunity, The Austin Hospital - Department of Infectious Diseases, Monash Medical Centre - Monash Infectious Diseases, Peter Doherty Institute for Infection and Immunity - Victorian Infectious Diseases Reference Laboratory, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - Peter Doherty Institute for Infection and Immunity, QIMR Berghofer Medical Research Institute - Infectious Diseases Programme, Monash University - Respiratory Medicine Laboratory, University of Melbourne - Department of Microbiology and Immunology (DMI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Peter Doherty Institute for Infection and Immunity, The University of Sydney - Sydney Cytometry Core Research Facility, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, Monash University - Department of Infectious Diseases, University of Melbourne - Peter Doherty Institute for Infection and Immunity, University of Melbourne - Department of Microbiology and Immunology (DMI), Monash University - Department of Infectious Diseases and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 60 (961,006)
Citation 5

Abstract:

Loading...

COVID-19, immune correlates, disease severity, IL-6R, hyperactivation

3.

High Precursor Frequency and Promiscuity in Αβ T Cell Receptor Pairing Underpin CD8+ T-Cell Responses to an Immunodominant SARS-CoV-2 Nucleocapsid Epitope

Number of pages: 35 Posted: 19 Dec 2020
University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Monash University - Infection and Immunity Program, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Monash University - Infection and Immunity Program, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, James Cook University - Centre for Molecular Therapeutics, Icahn School of Medicine at Mount Sinai - Department of Microbiology, University of Tasmania - School of Medicine, University of Tasmania - School of Medicine, University of Melbourne - Department of Microbiology and Immunology (DMI), Alfred Hospital - Lung Transplant Unit, Austin Hospital - Department of Infectious Diseases, Austin Hospital - Department of Infectious Diseases, University of Melbourne - Department of Microbiology and Immunology (DMI), The Austin Hospital - Department of Infectious Diseases, Austin Hospital - Department of Infectious Diseases, Monash University - Department of Infectious Diseases, Monash University - Department of Infectious Diseases, AFL House, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), Monash University - Infection and Immunity Program, University of Melbourne - Department of Microbiology and Immunology (DMI) and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 58 (980,173)

Abstract:

Loading...

4.

Rapid Recall and de novo T Cell Responses During SARS-CoV-2 Breakthrough Infection

Number of pages: 54 Posted: 30 Dec 2022
University of Melbourne - Department of Microbiology and Immunology (DMI), University of New South Wales (UNSW) - Kirby Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Infectious Diseases, University of Melbourne - Victorian Infectious Disease Reference Laboratory, University of Melbourne - Victorian Infectious Disease Reference Laboratory, University of Melbourne - Victorian Infectious Disease Reference Laboratory, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), St. Jude Children’s Research Hospital - Department of Immunology, University of Melbourne - Department of Microbiology and Immunology (DMI), Monash University - Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Monash University - Infection and Immunity Program, University of Melbourne - Victorian Infectious Disease Reference Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI) and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 29 (1,332,057)

Abstract:

Loading...

SARS-CoV-2, T cell, Breakthough